Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Brief Report

Whole genome sequence analysis of CPV-2 isolates from 1998 to 2020

Authors: Sajed Sarabandi, Hadi Pourtaghi

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Canine parvovirus-2 (CPV-2) is a virus with worldwide spread causing canine gastroenteritis. New strains of this virus have unique characteristics and are resistant to some vaccine strains. Therefore, understanding the root causes of resistance has proven to be of increasing concern to many scientists. This study collected 126 whole genome sequences of CPV-2 subtypes with specific collection dates from the NCBI data bank. The whole genome sequences of CPV-2 collected from different countries were analyzed to detect the new substitutions and update these mutations. The result indicated 12, 7, and 10 mutations in NS1, VP1, and VP2, in that respective order. Moreover, the A5G and Q370R mutations of VP2 are the most common changes in the recent isolates of the CPV-2C subtype, and the new N93K residue of VP2 is speculated to be the cause of vaccine failure. To summarize, the observed mutations, which are increasing over time, causes several changes in viral characteristic. A comprehensive understanding of these mutations can lead us to control potential future epidemics associated with this virus more efficiently.
Appendix
Available only for authorised users
Literature
2.
go back to reference Touihri L, Bouzid I, Daoud R, Desario C, El Goulli AF, Decaro N, Ghorbel A, Buonavoglia C, Bahloul C. Molecular characterization of canine parvovirus-2 variants circulating in Tunisia. Virus Genes. 2009;38(2):249–58.CrossRefPubMed Touihri L, Bouzid I, Daoud R, Desario C, El Goulli AF, Decaro N, Ghorbel A, Buonavoglia C, Bahloul C. Molecular characterization of canine parvovirus-2 variants circulating in Tunisia. Virus Genes. 2009;38(2):249–58.CrossRefPubMed
3.
go back to reference Mira F, Dowgier G, Purpari G, Vicari D, Di Bella S, Macaluso G, Gucciardi F, Randazzo V, Decaro N, Guercio A. Molecular typing of a novel canine parvovirus type 2a mutant circulating in Italy. Infect Genetics Evol. 2018;61:67–73.CrossRef Mira F, Dowgier G, Purpari G, Vicari D, Di Bella S, Macaluso G, Gucciardi F, Randazzo V, Decaro N, Guercio A. Molecular typing of a novel canine parvovirus type 2a mutant circulating in Italy. Infect Genetics Evol. 2018;61:67–73.CrossRef
4.
go back to reference Zhou P, Zeng W, Zhang X, Li S. The genetic evolution of canine parvovirus—a new perspective. PLoS ONE. 2017;12(3):0175035.CrossRef Zhou P, Zeng W, Zhang X, Li S. The genetic evolution of canine parvovirus—a new perspective. PLoS ONE. 2017;12(3):0175035.CrossRef
5.
go back to reference Giraldo-Ramirez S, Rendon-Marin S, Ruiz-Saenz J. Phylogenetic, evolutionary and structural analysis of canine parvovirus (CPV-2) antigenic variants circulating in Colombia. Viruses. 2020;12(5):500.CrossRefPubMedPubMedCentral Giraldo-Ramirez S, Rendon-Marin S, Ruiz-Saenz J. Phylogenetic, evolutionary and structural analysis of canine parvovirus (CPV-2) antigenic variants circulating in Colombia. Viruses. 2020;12(5):500.CrossRefPubMedPubMedCentral
6.
go back to reference Zhang R, Yang S, Zhang W, Zhang T, Xie Z, Feng H, Wang S, Xia X. Phylogenetic analysis of the VP2 gene of canine parvoviruses circulating in China. Virus Genes. 2010;40(3):397–402.CrossRefPubMed Zhang R, Yang S, Zhang W, Zhang T, Xie Z, Feng H, Wang S, Xia X. Phylogenetic analysis of the VP2 gene of canine parvoviruses circulating in China. Virus Genes. 2010;40(3):397–402.CrossRefPubMed
7.
go back to reference Hernandez-Blanco B, Catala-Lopez F. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: a systematic review of controlled clinical trials. Vet Microbiol. 2015;180(1–2):1–9.CrossRefPubMed Hernandez-Blanco B, Catala-Lopez F. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: a systematic review of controlled clinical trials. Vet Microbiol. 2015;180(1–2):1–9.CrossRefPubMed
8.
go back to reference Miao B, Chen S, Zhang X, Ma P, Ma M, Chen C, Zhang X, Chang L, Du Q, Huang Y, et al. T598 and T601 phosphorylation sites of canine parvovirus NS1 are crucial for viral replication and pathogenicity. Vet Microbiol. 2022;264: 109301.CrossRefPubMed Miao B, Chen S, Zhang X, Ma P, Ma M, Chen C, Zhang X, Chang L, Du Q, Huang Y, et al. T598 and T601 phosphorylation sites of canine parvovirus NS1 are crucial for viral replication and pathogenicity. Vet Microbiol. 2022;264: 109301.CrossRefPubMed
9.
go back to reference Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol. 2002;76(4):1884–91.CrossRefPubMedPubMedCentral Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol. 2002;76(4):1884–91.CrossRefPubMedPubMedCentral
10.
go back to reference Zadori Z, Szelei J, Lacoste M-C, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell. 2001;1(2):291–302.CrossRefPubMed Zadori Z, Szelei J, Lacoste M-C, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell. 2001;1(2):291–302.CrossRefPubMed
11.
go back to reference Muz D, Oğuzoğlu TÇ, Timurkan MÖ, Akın H. Characterization of the partial VP2 gene region of canine parvoviruses in domestic cats from Turkey. Virus Genes. 2012;44(2):301–8.CrossRefPubMed Muz D, Oğuzoğlu TÇ, Timurkan MÖ, Akın H. Characterization of the partial VP2 gene region of canine parvoviruses in domestic cats from Turkey. Virus Genes. 2012;44(2):301–8.CrossRefPubMed
12.
go back to reference Alexis V-A, Sonia V, Daniela S, Miguel G, Timothy H, Valentina F, Lisette L, Leonardo S. Molecular analysis of full-length vp2 of canine parvovirus reveals antigenic drift in CPV-2b and CPV-2c variants in central Chile. Animals. 2021;11(8):2387.CrossRefPubMedPubMedCentral Alexis V-A, Sonia V, Daniela S, Miguel G, Timothy H, Valentina F, Lisette L, Leonardo S. Molecular analysis of full-length vp2 of canine parvovirus reveals antigenic drift in CPV-2b and CPV-2c variants in central Chile. Animals. 2021;11(8):2387.CrossRefPubMedPubMedCentral
13.
go back to reference Wang H, Jin H, Li Q, Zhao G, Cheng N, Feng N, Zheng X, Wang J, Zhao Y, Li L, et al. Isolation and sequence analysis of the complete NS1 and VP2 genes of canine parvovirus from domestic dogs in 2013 and 2014 in China. Arch Virol. 2016;161(2):385–93.CrossRefPubMed Wang H, Jin H, Li Q, Zhao G, Cheng N, Feng N, Zheng X, Wang J, Zhao Y, Li L, et al. Isolation and sequence analysis of the complete NS1 and VP2 genes of canine parvovirus from domestic dogs in 2013 and 2014 in China. Arch Virol. 2016;161(2):385–93.CrossRefPubMed
15.
go back to reference Papaleo E, Saladino G, Lambrughi M, Lindorff-Larsen K, Gervasio FL, Nussinov R. The role of protein loops and linkers in conformational dynamics and allostery. Chem Rev. 2016;116(11):6391–423.CrossRefPubMed Papaleo E, Saladino G, Lambrughi M, Lindorff-Larsen K, Gervasio FL, Nussinov R. The role of protein loops and linkers in conformational dynamics and allostery. Chem Rev. 2016;116(11):6391–423.CrossRefPubMed
16.
go back to reference Allison AB, Organtini LJ, Zhang S, Hafenstein SL, Holmes EC, Parrish CR. Single mutations in the VP2 300 loop region of the three-fold spike of the carnivore parvovirus capsid can determine host range. J Virol. 2016;90(2):753–67.CrossRefPubMed Allison AB, Organtini LJ, Zhang S, Hafenstein SL, Holmes EC, Parrish CR. Single mutations in the VP2 300 loop region of the three-fold spike of the carnivore parvovirus capsid can determine host range. J Virol. 2016;90(2):753–67.CrossRefPubMed
17.
go back to reference Nguyen Manh T, Piewbang C, Rungsipipat A, Techangamsuwan S. Molecular and phylogenetic analysis of Vietnamese canine parvovirus 2C originated from dogs reveals a new Asia-IV clade. Transbound Emerg Dis. 2021;68(3):1445–53.CrossRefPubMed Nguyen Manh T, Piewbang C, Rungsipipat A, Techangamsuwan S. Molecular and phylogenetic analysis of Vietnamese canine parvovirus 2C originated from dogs reveals a new Asia-IV clade. Transbound Emerg Dis. 2021;68(3):1445–53.CrossRefPubMed
18.
go back to reference Saxena L, Chaturvedi U, Saxena S, Kumar GR, Sahoo A, Kumar S, Doley J, Rajmani R, Singh PK, Kumar R, et al. Characterization and in vitro expression of non-structural 1 protein of canine parvovirus (CPV-2) in mammalian cell line 2011. Saxena L, Chaturvedi U, Saxena S, Kumar GR, Sahoo A, Kumar S, Doley J, Rajmani R, Singh PK, Kumar R, et al. Characterization and in vitro expression of non-structural 1 protein of canine parvovirus (CPV-2) in mammalian cell line 2011.
19.
go back to reference De la Torre D, Mafla E, Puga B, Erazo L, Astolfi-Ferreira C, Ferreira AP. Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador. Vet World. 2018;11(4):480.CrossRefPubMedPubMedCentral De la Torre D, Mafla E, Puga B, Erazo L, Astolfi-Ferreira C, Ferreira AP. Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador. Vet World. 2018;11(4):480.CrossRefPubMedPubMedCentral
20.
go back to reference Lindner D, Walther C, Tennemann A, Beck-Sickinger AG. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization. Cell Signal. 2009;21(1):61–8.CrossRefPubMed Lindner D, Walther C, Tennemann A, Beck-Sickinger AG. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization. Cell Signal. 2009;21(1):61–8.CrossRefPubMed
21.
go back to reference Guo L, Yang S-L, Chen S-J, Zhang Z, Wang C, Hou R, Ren Y, Cao S, Guo W, Hao Z, et al. Identification of canine parvovirus with the Q370R point mutation in the VP2 gene from a giant panda (Ailuropoda melanoleuca). Virol J. 2013;10(1):1–7.CrossRef Guo L, Yang S-L, Chen S-J, Zhang Z, Wang C, Hou R, Ren Y, Cao S, Guo W, Hao Z, et al. Identification of canine parvovirus with the Q370R point mutation in the VP2 gene from a giant panda (Ailuropoda melanoleuca). Virol J. 2013;10(1):1–7.CrossRef
22.
go back to reference Ying H, Runxi X, Manfu Z. Expression or subcellular targeting of virus capsid proteins with cloning genome of a canine parvovirus from China. Res Vet Sci. 2009;87(2):239–41.CrossRefPubMed Ying H, Runxi X, Manfu Z. Expression or subcellular targeting of virus capsid proteins with cloning genome of a canine parvovirus from China. Res Vet Sci. 2009;87(2):239–41.CrossRefPubMed
23.
go back to reference Tuller T, Zur H. Multiple roles of the coding sequence 5’ end in gene expression regulation. Nucleic Acids Res. 2015;43(1):13–28.CrossRefPubMed Tuller T, Zur H. Multiple roles of the coding sequence 5’ end in gene expression regulation. Nucleic Acids Res. 2015;43(1):13–28.CrossRefPubMed
24.
go back to reference Dogonyaro BB, Bosman A-M, Sibeko KP, Venter EH, van Vuuren M. Genetic analysis of the VP2-encoding gene of canine parvovirus strains from Africa. Vet Microbiol. 2013;165(3–4):460–5.CrossRefPubMed Dogonyaro BB, Bosman A-M, Sibeko KP, Venter EH, van Vuuren M. Genetic analysis of the VP2-encoding gene of canine parvovirus strains from Africa. Vet Microbiol. 2013;165(3–4):460–5.CrossRefPubMed
25.
go back to reference Lin C-N, Chien C-H, Chiou M-T, Chueh L-L, Hung M-Y, Hsu H-S. Genetic characterization of type 2a canine parvoviruses from Taiwan reveals the emergence of an Ile324 mutation in VP2. Virol J. 2014;11(1):1–7.CrossRef Lin C-N, Chien C-H, Chiou M-T, Chueh L-L, Hung M-Y, Hsu H-S. Genetic characterization of type 2a canine parvoviruses from Taiwan reveals the emergence of an Ile324 mutation in VP2. Virol J. 2014;11(1):1–7.CrossRef
26.
go back to reference Agbandje-McKenna M, Llamas-Saiz AL, Wang F, Tattersall P, Rossmann MG. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure. 1998;6(11):1369–81.CrossRefPubMed Agbandje-McKenna M, Llamas-Saiz AL, Wang F, Tattersall P, Rossmann MG. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure. 1998;6(11):1369–81.CrossRefPubMed
27.
go back to reference Strassheim ML, Gruenberg A, Veijalainen P, Sgro J-Y, Parrish CR. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology. 1994;198(1):175–84.CrossRefPubMed Strassheim ML, Gruenberg A, Veijalainen P, Sgro J-Y, Parrish CR. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology. 1994;198(1):175–84.CrossRefPubMed
28.
go back to reference Boros A, Albert M, Urban P, Herczeg R, Gaspar G, Balazs B, Csagola A, Pankovics P, Gyenesei A, Reuter G. Unusual “Asian-origin’’ 2c to 2b point mutant canine parvovirus (Parvoviridae) and canine astrovirus (Astroviridae) co-infection detected in vaccinated dogs with an outbreak of severe haemorrhagic gastroenteritis with high mortality rate in Hungary. Vet Res Commun. 2022;46(4):1355–61.CrossRefPubMedPubMedCentral Boros A, Albert M, Urban P, Herczeg R, Gaspar G, Balazs B, Csagola A, Pankovics P, Gyenesei A, Reuter G. Unusual “Asian-origin’’ 2c to 2b point mutant canine parvovirus (Parvoviridae) and canine astrovirus (Astroviridae) co-infection detected in vaccinated dogs with an outbreak of severe haemorrhagic gastroenteritis with high mortality rate in Hungary. Vet Res Commun. 2022;46(4):1355–61.CrossRefPubMedPubMedCentral
29.
go back to reference Decaro N, Buonavoglia C, Barrs V. Canine parvovirus vaccination and immunisation failures: are we far from disease eradication? Vet Microbiol. 2020;247:108760CrossRefPubMedPubMedCentral Decaro N, Buonavoglia C, Barrs V. Canine parvovirus vaccination and immunisation failures: are we far from disease eradication? Vet Microbiol. 2020;247:108760CrossRefPubMedPubMedCentral
Metadata
Title
Whole genome sequence analysis of CPV-2 isolates from 1998 to 2020
Authors
Sajed Sarabandi
Hadi Pourtaghi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02102-2

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.